Literature DB >> 8276795

Construction, expression, and activity of a bivalent bispecific single-chain antibody.

W D Mallender1, E W Voss.   

Abstract

This report describes the design, construction, and expression of a bivalent bispecific single-chain antibody (SCA) protein in Escherichia coli. The bispecificity of the bivalent protein was based on two previously constructed monovalent single-chain antibody molecules possessing distinct specificities, SCA 4-4-20 (anti-fluorescein) and SCA 04-01 (anti-single-stranded DNA). A flexible linker, modeled after a secreted fungal cellulase protein, was incorporated as the interdomain linker covalently joining the two active sites. Bivalent bispecific SCA protein that accumulated in bacteria as insoluble inclusion bodies was harvested, denatured, refolded, and affinity-purified in vitro. Affinity-purified bivalent bispecific SCA showed nearly identical ligand binding properties at each site relative to the individual monovalent single-chain antibody prototype molecules. In both solid and solution phase binding assays, the bivalent bispecific single-chain antibody simultaneously bound both ligands (fluorescein and (dT)6). Construction of a model bivalent bispecific molecule provides a foundation for future assembly of similar molecules designed to identify parameters involved in enhanced binding of antibodies due to avidity and dual specificity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8276795

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Cytotoxic enhancement of a bispecific diabody by format conversion to tandem single-chain variable fragment (taFv): the case of the hEx3 diabody.

Authors:  Ryutaro Asano; Keiko Ikoma; Ippei Shimomura; Shintaro Taki; Takeshi Nakanishi; Mitsuo Umetsu; Izumi Kumagai
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

2.  Antibody fragments: hope and hype.

Authors:  Aaron L Nelson
Journal:  MAbs       Date:  2010-01-27       Impact factor: 5.857

3.  Fab-based bispecific antibody formats with robust biophysical properties and biological activity.

Authors:  Xiufeng Wu; Arlene J Sereno; Flora Huang; Steven M Lewis; Ricky L Lieu; Caroline Weldon; Carina Torres; Cody Fine; Micheal A Batt; Jonathan R Fitchett; Andrew L Glasebrook; Brian Kuhlman; Stephen J Demarest
Journal:  MAbs       Date:  2015       Impact factor: 5.857

4.  Two functional S100A4 monomers are necessary for regulating nonmuscle myosin-IIA and HCT116 cell invasion.

Authors:  Reniqua P House; Maria Pozzuto; Purvi Patel; Natalya G Dulyaninova; Zhong-Hua Li; Wendy D Zencheck; Michele I Vitolo; David J Weber; Anne R Bresnick
Journal:  Biochemistry       Date:  2011-07-13       Impact factor: 3.162

5.  Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis.

Authors:  Bryan D Choi; Patrick C Gedeon; Chien-Tsun Kuan; Luis Sanchez-Perez; Gary E Archer; Darell D Bigner; John H Sampson
Journal:  J Immunol Methods       Date:  2013-06-24       Impact factor: 2.303

6.  Optimizing the stability of single-chain proteins by linker length and composition mutagenesis.

Authors:  C R Robinson; R T Sauer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

7.  Lupus-derived autoantibodies with dual autoactivity: anti-DNA and anti-Fc. I. Comparison of IgG autoreactivities with single-chain Fv derivatives.

Authors:  C A Rumbley; E W Voss
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

Review 8.  Redirection of cellular cytotoxicity. A two-step approach using recombinant single-chain Fv molecules.

Authors:  A J George; J A Titus; C R Jost; I Kurucz; P Perez; S M Andrew; P J Nicholls; J S Huston; D M Segal
Journal:  Cell Biophys       Date:  1995-06

9.  Cloned transgenic farm animals produce a bispecific antibody for T cell-mediated tumor cell killing.

Authors:  Ludger Grosse-Hovest; Sigrid Müller; Rosa Minoia; Eckhard Wolf; Valeri Zakhartchenko; Hendrik Wenigerkind; Caroline Lassnig; Urban Besenfelder; Mathias Müller; Simon D Lytton; Gundram Jung; Gottfried Brem
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-22       Impact factor: 11.205

10.  Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action.

Authors:  Zhengxing Qu; David M Goldenberg; Thomas M Cardillo; Victoria Shi; Hans J Hansen; Chien-Hsing Chang
Journal:  Blood       Date:  2007-11-19       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.